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O B J E C T I V E S This study aimed to determine the quantitative low-ﬂow threshold for stress-induced
perfusion defects with severe angina and/or signiﬁcant ST-segment depression during dipyridamole hyperemia.
B A C KG ROUND Vasodilator stress reveals differences in regional perfusion without ischemia in
most patients. However, in patients with a perfusion defect, angina, and/or signiﬁcant ST-segment
depression during dipyridamole stress, quantitative absolute myocardial perfusion and coronary ﬂow
reserve (CFR) at the exact moment of deﬁnite ischemia have not been established. Deﬁning these
low-ﬂow thresholds of angina or ST-segment changes may offer insight into physiological disease
severity in patients with atherosclerosis.
METHOD S Patients underwent rest–dipyridamole stress positron emission tomography (PET) with
absolute ﬂow quantiﬁcation in ml/min/g. Deﬁnite ischemia was deﬁned as a new or worse perfusion
defect during dipyridamole stress with signiﬁcant ST-segment depression and/or severe angina
requiring pharmacological treatment. Indeterminate clinical features required only 1 of these 3
abnormalities. The comparison group included patients without prior myocardial infarction, or angina or
electrocardiographic changes after dipyridamole.
R E S U L T S In 1,674 sequential PET studies, we identiﬁed 194 (12%) with deﬁnite ischemia, 840 (50%)
studies with no ischemia, and 301 (18%) that were clinically indeterminate. A vasodilator stress perfusion
cutoff of 0.91 ml/min/g optimally separated deﬁnite from no ischemia with an area under the
receiver-operator characteristic curve (AUC) of 0.98 and a CFR cutoff of 1.74 with an AUC  0.91,
reﬂecting excellent discrimination at the exact moment of deﬁnite ischemia.
CONC L U S I O N S Thresholds of low myocardial vasodilator stress perfusion in ml/min/g and CFR sharply
separate patients with angina or ST-segment change from those without these manifestations of ischemia during
dipyridamole stress with excellent discrimination. Stress ﬂow below 0.91 ml/min/g in dipyridamole-induced PET
perfusion defects causes signiﬁcant ST-segment depression and/or severe angina. However, when the worst
vasodilator stress ﬂow exceeds 1.12 ml/min/g, these manifestations of ischemia occur rarely. (J Am Coll Cardiol
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991uring coronary vasodilator stress, most pa-
tients experience hyperemia in excess of
myocardial metabolic need, because vaso-
dilating agents uncouple coronary blood
flow from demand. However, in a subset of pa-
tients, myocardial perfusion drops below metabolic
demand in a portion of the myocardium, particu-
larly in the subendocardium (1). Such patients may
experience severe angina, significant ST-segment
depression, and an imaging abnormality during
See page 999
vasodilator stress. Therefore, physiological imaging
during vasodilator stress associated with these
symptoms reflects absolute myocardial perfusion
and coronary flow reserve (CFR) at the exact
moment of definite ischemia. Defining these low-
flow thresholds of ischemia may offer insight into
physiological disease severity in patients with ad-
vanced atherosclerosis, as contrasted with young
normal volunteers (2) or intermediate values in the
larger population with subclinical, nonobstructive
coronary atherosclerosis.
METHODS
All patients underwent rest–dipyridamole stress
myocardial perfusion positron emission tomogra-
phy (PET) with absolute flow quantification at the
Weatherhead PET Center for Preventing and Re-
versing Atherosclerosis of the University of Texas
Medical School at Houston and Memorial Her-
mann Hospital. Subjects gave written informed
consent approved by the institutional review board.
Standard demographic information, cardiac history,
and risk factors were recorded. Patients represented
the entire spectrum of coronary disease, including
assessment or follow-up of known coronary artery
disease (CAD), second opinions on revasculariza-
tion procedures, prior positive stress tests, coronary
calcification by computed tomography (CT), chest
pain or other symptoms, or risk factors.
PET acquisition protocol. Our acquisition and pro-
cessing protocol has been extensively described
(2–5). Patients were instructed to fast for 4 h and
abstain from caffeine, theophylline, and cigarettes
for 24 h. Cardiac imaging with prospective mea-
surement of absolute flow was performed between
March 2007 and July 2010 using a Discovery ST
PET scanner with hybrid 16-slice CT scanner (GE
Healthcare, Waukesha, Wisconsin) in 2-dimensionalmode with an in-plane resolution of approximately
6 to 7 mm full width at one-half maximum (6).
Rest emission data were obtained over 7 min
beginning immediately upon intravenous injection
of 35 to 50 mCi (1,295 to 1,850 MBq) of
generator-produced Rb-82 (Bracco Diagnostics,
Princeton, New Jersey). Images contained 24 to 60
million total counts, of which 12 to 30 million were
true coincidence counts. The first 2 min of the
emission images were binned to form the arterial
input data. The last 5 min of the emission images
were binned to form the myocardial uptake data.
Immediately after completion of the resting scan,
dipyridamole (142 g/kg/min) was infused for 4
min. Four minutes after completion of dipyri-
damole infusion, the same dose of radiotracer was
given. Stress emission images were acquired for 7
min and binned into arterial and myocardial
images as for the resting scan. CT scans
for attenuation correction were acquired
before rest and after stress emission
imaging and aligned to emission data as
previously reported (3).
Severe angina relieved only after intra-
venous aminophylline, sublingual nitro-
glycerin, and/or intravenous metoprolol
was recorded, distinct from nonischemic
chest symptoms due to dipyridamole.
Continuous 12-lead electrocardiogram
(ECG) monitoring during dipyridamole
stress identified significant, 1-mm ST-
segment depression. Hemodynamic pa-
rameters of heart rate and blood pressure
were recorded at rest and during dipyri-
damole stress.
To demonstrate the universality of our
findings, distinct from hardware configurations
or radionuclides, we also performed a minority of
studies using 2 rotating-rod PET scanners. Be-
tween February 1993 and May 1997, 538 studies
were performed on the original University of
Texas cesium fluoride scanner (7). Between Sep-
tember 2006 and April 2010, 56 studies were
performed on an mPower scanner (Positron Cor-
poration, Fishers, Indiana) (8). Quantitative
phantom studies showed accurate and compara-
ble activity recovery by all scanners. For the
University of Texas scanner, 15 to 20 mCi (550
to 750 MBq) of cyclotron-produced N-13 am-
monia were used instead of Rb-82, with the last
15 min of the emission images forming the
myocardial uptake data. Flow was quantified
A B B
A N D
AUC
CAD
CFR
CT
ECG
electr
LV
PCI
interv
PET
tomog
PRP
ROC
charausing our radionuclide-specific model (9).R E V I A T I O N S
A C R O N YM S
area under the curve
coronary artery disease
coronary flow reserve
computed tomography
electrocardiogram/
ocardiography
left ventricle/ventricular
percutaneous coronary
ention
positron emission
raphy
pressure-rate product
receiver-operator
u
(
w
d
o
A
g
o
u
5
a
c
F
y
o
t
o
m
fi
g
t
r
a
w
u
c
b
e
i
t
n
s
l
s
t
e
L
s
p
t
(
b

M
p
p
t
m
g
c
o

e
o
n
b
s
t
c
t
i
d
a
t
o
w
c
PET  pos
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 9 , 2 0 1 1
S E P T E M B E R 2 0 1 1 : 9 9 0 – 8
Johnson and Gould
Ischemic Thresholds for Stress Flow and CFR
992Image reconstruction. Images were reconstructed
sing filtered backprojection with a ramp filter
cutoff: 6.5 mm), and then processed by a Butter-
orth filter (cutoff: 0.50 cycles/cm, rolloff: 10 dB/
ecade). Fused emission and transmission images
ptimized coregistration by shifting as needed.
fter reconstruction, a 3-dimensional rotation al-
orithm generated true short- and long-axis views
f the left ventricle (LV) from transaxial images
sing previously described quantitative software (3–
). Circumferential profiles of maximum LV radial
ctivity for each true short-axis slice were used to
onstruct 2-dimensional topographic views as in
igure 1. Visual display, but not quantitative anal-
sis, utilized bilinear interpolation for figures.
Absolute myocardial ﬂow. Peak integrated activity
ver an approximate 2  2-mm circular area,
ypically in the left atrium or thoracic aorta, but
ccasionally in the central LV cavity, was deter-
ined from transaxial images acquired during the
rst 2 min after each radiotracer injection. Inte-
rated myocardial activity on late images was de-
ermined from topographical LV maps. For each
adial segment of every short-axis slice, integrated
rterial input and integrated myocardial uptake
ere used to compute absolute myocardial flow
sing an established model (9) implemented using
ustom software. Partial volume corrections were
ased on quantitative phantom studies specific for
ach scanner (10). The 21-slice (each slice approx-
mately 2.7 to 3.8 mm thick) by 64 radial pixel
LV Quadrants in Cardiac PET
left ventricular (LV) myocardial perfusion by quadrants, as applied
data in later ﬁgures. Three-dimensional tomographic data are
into 2-dimensional topographic data and shown by quadrant.
itron emission tomography.opographic flow map from Positron and GE scan- hers was smoothed using a 5  5 pixel average to
suppress noise introduced by the flow model. CFR
was computed as the stress-to-rest ratio. Worst
single pixel flow during dipyridamole stress and
worst CFR were recorded by software. As flow is
computed on a pixel-by-pixel basis, the worst pixel
may be located at different points in rest, stress, and
CFR images. Therefore, worst CFR may not repre-
sent worst stress flow divided by worst rest flow.
Additionally, average CFR may not equal the ratio of
average stress to rest flow. Average quadrant flows do
not differ significantly in normal volunteers (2).
Quantitative endpoints and classiﬁcation. Four basal
lices were not used for quantitative analysis due to
ow counts in the membranous interventricular
eptum. Two apical slices were not used for quan-
itative analysis due to potential partial volume
rrors caused by partial thickness slices through the
V apex and apical motion. Combined size and
everity of perfusion defects was quantified by
ercent of the whole topographic image with rela-
ive activity less than 60% of maximum activity
100%), which is more than 6 standard deviations
elow mean activity in normal volunteers (2).
A significant perfusion defect was defined as
2% of the LV below 60% of maximum activity.
yocardial infarction was defined as significant
erfusion defects at rest and stress. A stress-induced
erfusion defect was defined as a 5% change from
he resting scan in the amount of LV below 60% of
aximum activity.
Studies were classified into mutually exclusive
roups. Definite ischemia was defined as a signifi-
ant stress-induced perfusion defect and the devel-
pment of either or both of ST-segment depression
1 mm from baseline during dipyridamole hyper-
mia or severe angina requiring intravenous amin-
phylline, sublingual nitroglycerin, and/or intrave-
ous metoprolol for resolution. In patients whose
aseline ECG limited interpretation of ST-
egment changes (left bundle branch block or ven-
ricular paced rhythm), the ST-segment depression
riterion was not used. Indeterminate clinical fea-
ures were defined as at least 1 of a dipyridamole-
nduced perfusion defect, significant ST-segment
epression, or severe angina requiring intravenous
minophylline, sublingual nitroglycerin, and/or in-
ravenous metoprolol for resolution. Studies with-
ut myocardial infarction and without ischemia
ere classified as nonischemic. Studies with myo-
ardial infarction but no ischemia were classified asFigure 1.
Display of
to clinical
reorientedaving only scar.
f
p
c
a
a
t
n
g
n
s
a
c
A
a
c
1
s
m
w
t
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 9 , 2 0 1 1
S E P T E M B E R 2 0 1 1 : 9 9 0 – 8
Johnson and Gould
Ischemic Thresholds for Stress Flow and CFR
993A small number of patients with studies at most
40 days before and within 100 days after percuta-
neous coronary intervention (PCI) were compared
to determine the effects of revascularization on
absolute flow endpoints, as pilot observations were
limited in size by funding.
Systolic blood pressure and heart rate were re-
corded both at rest and at peak stress imaging. The
quantitative perfusion threshold that caused isch-
emia was normalized to a pressure-rate product
(PRP) of 7,000 at rest (equivalent to a standardized
heart rate to 70 beats/min and systolic blood pres-
sure of 100 mmHg) and 10,000 at vasodilator stress
(equivalent to a standardized heart rate of 100
beats/min and systolic pressure of 100 mm Hg),
based on average values in our cohort. PRP adjust-
ment was performed to explore for any residual
relationship between PRP and hyperemia after
coronary vasodilation.
Statistical methods. All statistical analyses were per-
ormed using R version 2.12 (11) with the ROCR
ackage (12) used to compute receiver-operator
haracteristic (ROC) curves, sensitivity, specificity,
nd area under the curve (AUC). Continuous vari-
bles are summarized as mean  standard devia-
ion, or median (interquartile range) for non-
ormal distributions, and were compared between
roups using the t test (or Kruskal-Wallis test for
on-normal distributions), which was paired for
erial studies in the same patient. Frequency vari-
Table 1. Baseline Demographics and Clinical Characteristics
No Ischemia
Indeterm
F
Number of studies 840 (50%) 3
Severe angina 0 (0%)
Stress ST-segment depression 0 (0%)
Stress-induced defect 0 (0%) 2
Rest SBP, mm Hg 116 17 1
Rest HR, beats/min 61 11
Stress SBP, mm Hg 118 16 1
Stress HR, beats/min 90 15
Age 53 17
Male sex 656 (78%) 2
Prior PCI 118 (14%) 1
Prior CABG 43 (5%)
Recent angina 20 (2%)
Diabetes 63 (8%)
Current tobacco use 42 (5%)
Hypertension 334 (40%) 1
Hyperlipidemia 597 (71%) 2
Family history of atherosclerosis 576 (69%) 2
Values are n (%) or mean  SD. p values compared to no ischemia versus ind
CABG  coronary artery bypass grafting; HR  heart rate; N/A  not applicable; Pbles are summarized as number (percent) and
ompared using a chi-square or Fisher exact test.
ssociation between paired and continuous vari-
bles is summarized using the square of the Pearson
orrelation coefficient. Box plots identify outliers as
.5 times the interquartile range. Worst vasodilator
tress flow and worst CFR cutoffs separating groups
atch sensitivity to specificity. All applicable tests
ere 2-tailed, and p  0.05 was considered statis-
ically significant.
RE SULTS
A total of 1,674 PET studies were performed in
1,370 unique patients. Table 1 lists demographic
and clinical characteristics at each study. Studies
with ischemia had higher burdens of cardiovascular
risk factors, prior mechanical revascularization, or
recent clinical angina.
A total of 194 (12%) studies demonstrated definite
ischemia (a significant new or worse perfusion defect
during dipyridamole plus either or both of significant
ST-segment depression or severe angina requiring
intravenous aminophylline, sublingual nitroglycerin,
and/or intravenous metoprolol for resolution); 301
(18%) studies demonstrated indeterminate clinical
features (at least 1 of a dipyridamole-induced defect,
significant ST-segment depression, or severe angina);
and 339 (20%) studies demonstrated only scar;
te Clinical
res p Value Deﬁnite ischemia p Value
8%) N/A 194 (12%) N/A
9%) N/A 150 (77%) N/A
6%) N/A 131 (68%) N/A
1%) N/A 194 (100%) N/A
18 0.001 127 18 0.001
12 0.82 62 12 0.24
18 0.001 131 21 0.001
15 0.004 87 14 0.005
11 0.001 64 9 0.001
0%) 0.46 171 (88%) 0.001
7%) 0.001 51 (26%) 0.001
0%) 0.001 65 (34%) 0.001
2%) 0.001 73 (38%) 0.001
0%) 0.27 11 (6%) 0.44
%) 0.045 12 (6%) 0.48
3%) 0.001 109 (56%) 0.001
4%) 0.001 165 (85%) 0.001
4%) 0.08 149 (77%) 0.024
inate clinical features.ina
eatu
01 (1
57 (1
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CI  percutaneous coronary intervention; SBP  systolic blood pressure.
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994whereas 840 (50%) studies demonstrated no ischemia
or scar.
The worst vasodilator stress flow was 0.47 0.26
ml/min/g in studies with definite ischemia com-
pared with 1.56 0.54 ml/min/g in studies without
ischemia or scar (p  0.001). The optimal separa-
ion between these groups occurred at a vasodi-
ator stress flow cutoff of 0.91 ml/min/g with an
UC  0.98. The worst CFR was 1.21  0.57 in
tudies with definite ischemia compared with
.47  0.77 in studies without ischemia or scar
p  0.001). The optimal separation between
these groups occurred at a CFR cutoff of 1.74
with an AUC  0.91. In studies with definite
ischemia, 77 (40%) had worst CFR 1 (myocar-
dial steal), whereas in studies without ischemia,
12 (1.4%) had worst CFR 1.
Studies with indeterminate clinical features had a
worst vasodilator stress flow of 0.81  0.47 ml/
min/g (p 0.001 compared with no ischemia). The
optimal separation between these groups occurred
at a cutoff of 1.12 ml/min/g with an AUC  0.86.
Figure 2. Examples of Clinical Categories of Patients
Although quantitative data were obtained for all quadrants, the po
single view for publication efﬁciency. (A) Deﬁnite ischemia. Rest–di
defect with lowest stress ﬂow of 0.3 ml/min/g and coronary ﬂow re
als to an occluded, dominant left circumﬂex coronary artery. In the
3.9 are excellent. (B) No ischemia with dense coronary calciﬁcations
ease for which bypass surgery was recommended, leading to PET f
cant stress-induced perfusion defect with high stress perfusion of 3
diffuse, calciﬁc, nonobstructive coronary atherosclerosis and no ﬂ
dipyridamole PET shows a moderate, anterior, stress-induced pe
stress perfusion of 1.6 ml/min/g and adequate CFR of 2.9 in the defhe worst CFR was 1.72  0.70 in studies with
ndeterminate clinical features (p  0.001 com-
ared with no ischemia). The optimal separation
etween these groups occurred at a CFR cutoff of
.03 with an AUC  0.77. In studies with inde-
erminate clinical features, 43 (14.3%) had myocar-
ial steal.
The optimal separation between the indetermi-
ate and definite ischemia groups occurred at a
orst vasodilator stress flow cutoff of 0.52 ml/min/g
ith AUC  0.74 and worst CFR cutoff of 1.36
ith AUC  0.72. The lower AUC for separating
he indeterminate from definite ischemia groups is
xpected from the well-known improvement in
iagnostic accuracy from aggregating (as in the
efinite ischemia group) individual endpoints (as in
he indeterminate group).
Figure 2 illustrates rest–dipyridamole PET in the
o ischemia, indeterminate, and definite ischemia
roups. Figure 3 shows the box plots and cutoff
alues for these groups along with the optimal
utoff values for worst vasodilator stress flow and
n emission tomography (PET) images show only the signiﬁcant
amole PET shows a severe, inferior, stress-induced perfusion
e (CFR) of 0.6, indicating myocardial steal associated with collater-
al inferior area, vasodilator stress ﬂow of 2.1 ml/min/g and CFR of
oronary arteriogram reportedly showing moderate 3-vessel dis-
second opinion. Rest–dipyridamole PET shows no clinically signiﬁ-
l/min/g and CFR of 4.1, indicating excellent ﬂow capacity with
-limiting stenosis. (C) Indeterminate clinical features. Rest–
on defect in the distribution of a diagonal but with adequatesitro
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995ROC curves for separating no ischemia from the
other groups. Less than 10% (9.8%) of the definite
ischemia group had flow above the ischemic thresh-
old of 0.91 ml/min/g. In the group without isch-
emia, 10% (9.5%) had flows below this threshold.
Figure 4 illustrates changes in quantitative PET
measurements after PCI. Although quantitative
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Figure 3. Low-Flow Ischemic Thresholds
Box plot (A) and receiver-operator characteristic curves (B) for wors
ischemia groups, and those with indeterminate clinical features alo
the curve.
Figure 4. Example of Improvement After PCI
Relative PET perfusion images and quadrant average vasodilator str
coronary intervention (PCI) of the proximal right coronary artery. Ba
Rest–dipyridamole PET shows resting perfusion heterogeneity and
ml/min/g and CFR of 1.0, with worst stress ﬂow of 0.2 ml/min/g an
showed severe stenosis (yellow arrow) with collaterals only from th
improved to 1.3 ml/min/g and CFR improved to 3.0, with worst vas
resolution of myocardial steal. No medication changes were made
image is the membranous septum that has no perfusion and is a n
rants, the PET images show only the signiﬁcant single view for publicatdata were obtained for all quadrant views shown in
Figure 1, the PET images of Figure 2 and Figure 4
how only the significant single view for publication
fficiency.
Average PRP at rest was 7,351  1,869 mm
g/min and increased to 10,861  2,504 mm
g/min during peak dipyridamole stress. PRP cor-
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ne diagnostic PET was done for recent, mild exertional angina.
vere, inferior, stress-induced defect with average stress ﬂow of 0.4
R of 0.5, indicating localized myocardial steal. Angiography
ft system. After successful PCI, average vasodilator stress ﬂow
ator stress ﬂow of 1.0 ml/min/g and worst CFR of 1.8, indicating
een studies. The small blue region in the upper right of the CFR
al ﬁnding. Although quantitative data were obtained for all quad-B
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996related significantly but weakly with whole LV
flow, stronger at rest (r2  0.22, p  0.001) than
uring stress (r2  0.08, p  0.001), as expected
given the uncoupling of coronary flow from meta-
bolic demand with dipyridamole. Therefore, adjust-
ing the worst vasodilator stress flow and CFR to
PRP did not improve the AUC by ROC analysis
(worst stress flow cutoff: 0.89 ml/min/g at 10,000
PRP, AUC  0.99; worst CFR cutoff: 1.75 at
10,000/7,000 PRP, AUC  0.91). Separately ana-
lyzing the 2 scanners accounting for over 96% of the
studies showed similar results to the whole group.
Of the 302 studies in the indeterminate group,
100 (33%) had worst vasodilator stress flows below
the ischemic threshold and reversible defects 10%
of the LV, but no severe angina or significant
ST-segment changes with dipyridamole. Another
98 (32%) studies had worst vasodilator stress flows
below the ischemic threshold but with reversible
defects 10% of the LV, roughly evenly split
between defects sized 5% and 5% to 10% of the
LV. Only 41 (14%) of studies had worst vasodilator
stress flows between the 2 nonischemic thresholds,
of which only 6 (2%) had reversible defects 10%
of the LV. Of the remaining 66 (22%) studies with
worst vasodilator stress flows above the ischemic
thresholds, only 8 (3%) had reversible defects10%
of the LV.
For pilot data, 12 patients underwent quantita-
tive PET studies before (median: 5 days, interquar-
tile range: 1 to 8 days, maximum: 38 days) and after
(median: 17 days, interquartile range: 12 to 27 days,
maximum: 96 days) PCI. In the treated territory the
average vasodilator stress perfusion increased from
0.98  0.47 to 1.43  0.36 ml/min/g (p  0.018)
and average CFR improved from 1.77  0.99 to
2.79  0.81 (p  0.005). Severe, dipyridamole-
induced angina requiring intravenous aminophyl-
line, sublingual nitroglycerin, and/or intravenous
metoprolol for resolution disappeared in all cases
after PCI, as did significant ST-segment depression
in 3 of 5 cases. Dipyridamole-induced relative
perfusion defect severity 60% of maximum de-
creased from 26% (interquartile range: 16% to 45%)
to 5% (interquartile range: 1% to 13%) of the LV
(p  0.009).
D I SCUS S ION
Regional vasodilator stress flow below 0.91 ml/
min/g in dipyridamole-induced PET perfusion de-
fects causes significant ST-segment depression
and/or severe angina requiring intravenous amino-phylline, sublingual nitroglycerin, and/or intrave-
nous metoprolol. However, when the worst vasodi-
lator stress flow exceeds 1.12 ml/min/g, these
manifestations of ischemia occur rarely. Between
0.91 and 1.12 ml/min/g, angina or ST-segment
change may or may not develop. For this narrow
intermediate range, the size and severity of relative
vasodilator stress-induced defects and surrounding
flows indicating the extent of diffuse disease addi-
tionally quantify its extent and severity. Average
vasodilator stress flow and CFR in myocardial
segments supplied by severely stenotic epicardial
arteries improve to above these thresholds after
successful PCI.
Dipyridamole and other vasodilatory stressors
produce fundamentally different stress physiology
than exercise. One key difference is disruption of
coronary autoregulation by these vasodilators, with
resulting potential subendocardial steal distal to
flow-limiting stenosis, as well documented experi-
mentally. In addition, exercise-induced coronary
vasoconstriction (13) or increased metabolic de-
mand from high heart rate and increased myocar-
dial contractility may alter the ischemic thresholds
between exercise and vasodilation. Sympathetic
coronary vasoconstriction during exercise, particu-
larly in CAD patients with endothelial dysfunction,
and higher perfusion pressure with exercise com-
pared with vasodilator stress may alter coronary
flow in complex, unpredictable ways. Therefore,
comparing the PRP in the dipyridamole group with
that which might be produced during a Bruce stress
test is conjecture beyond the scope of our data.
However, quantitative perfusion during vasodilator
stress offers valid insights into physiological severity
of diffuse and segmental disease, perhaps even the
optimal measure of severe structural flow limita-
tions independent of numerous physiologic factors
that worsen ischemia with exercise in addition to a
fixed structural lesion (14). In an individual patient,
the lack of definite ischemia during vasodilator
stress may not exclude ischemia during exercise
stress.
The differential prevalence of recent angina at the
bottom of Table 1 (2% for no ischemia, 12% for
indeterminate features, and 38% for definite isch-
emia) suggests an approximate correlation between
vasodilator ischemia and exercise ischemia. More
frequent angina with vasodilator stress than with
exercise may occur, perhaps due to “subendocardial
steal,” reflected as lowered “average transmural”
flow in our data. Additionally, fractional flow re-
serve is measured during vasodilator stress and not
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997exercise stress, yet has proven clinical utility despite
being a relative coronary flow metric based on
surrogate pressure measurements. Thus, vasodilator
manifestations of ischemia relate to exercise-
induced ischemia, and their potential to guide
clinical management requires further study in addi-
tion to the basic human physiology reported here.
A low absolute flow and/or CFR can occur both
with and without a relative uptake defect as in diffuse
disease. Since diffuse coronary disease, commonly
associated with all stenoses, does not cause relative
perfusion defects, it is essential, not redundant, to
include quantitative relative perfusion defects as done
here for comprehensive analysis of disease severity
needed for management decisions. Our study identi-
fies the low-flow thresholds causing angina or
ST-segment changes within dipyridamole-induced
erfusion defects. However, absence of angina or
T-segment change does not exclude ischemia at
hese flow thresholds where “ischemia” may be “silent”
r defined in many different ways, such as wall motion
hanges or lactate production.
In the indeterminate group, simultaneous appli-
ation of flow thresholds and reversible defect size
dentifies 3 subgroups. One-third of this group has
n ischemic burden large and severe enough to
arrant potential mechanical revascularization;
ne-third have a severe but small ischemic burden
hat may respond to initial, aggressive medical
herapy with PCI as a fall-back option. One-third
ave adequate flow but a small perfusion defect that
rises due to heterogeneity, likely from distal or
iffuse disease or microvascular dysfunction (4).
In the no ischemia category, 80 of 840 (9.5%) had
worst stress flow 0.91 ml/min/g. Of these 80
patients, 60 (75%) had a worst CFR 1.74, and 27
(34%) had a worst CFR 2.03. As can be seen,
examining worst stress flow and CFR together reveals
that a large number of patients without any clinical
manifestations of ischemia (no vasodilator-induced
PET defect with no significant ECG changes or
severe angina during dipyridamole) who have a worst
stress flow below the cutoff 0.91 ml/min/g have
elatively intact worst CFR 1.74 to 2.03. Using
orst stress flow alone would therefore give a less
omplete picture of the coronary physiology.
Comparison to existing literature. In a cohort of 26
atients pre-selected and actively undergoing PCI
15), absolute myocardial perfusion was measured
sing myocardial contrast echocardiography. Isch-
mia was defined by intracoronary ECG as ST-
egment elevation 1 mm at the end of a 1-min
alloon occlusion of the coronary artery. ROC flnalysis identified a flow cutoff of 0.37 ml/min/g
uring coronary occlusion with an AUC  0.99,
omparable to our AUC values from a larger num-
er of patients with a broader spectrum of CAD.
he lower flow threshold in this small population
ikely relates to different flow-measuring methods,
xclusive selection of patients scheduled for PCI, and
ntracoronary ECG changes occurring earlier than
linical angina during the ischemic cascade (16).
Invasive studies using Doppler velocity CFR
rom 10 studies in a total of 816 patients found
ptimal cutoffs from 1.7 to 2.1 with AUC 0.65 to
.85 (17) when compared with noninvasive func-
ional imaging. These values agree with our nonin-
asive CFR threshold of 1.74 with AUC 0.91 for
efinite ischemia. However, our work extends these
rior results by providing a noninvasive absolute
ow threshold for ischemia, in addition to a CFR
schemic threshold, derived from a much larger
ohort than all of these studies combined.
Study limitations. Cardiac PET quantifies average
ransmural flow and can distinguish subendocardial
rom subepicardial perfusion only under conditions
f marked hypertrophy. During vasodilation, sub-
ndocardial flow may be worse than subepicardial
ow, but our transmural average flow thresholds
eflect whatever composite flow causes angina or
T-segment change within the dipyridamole-
nduced perfusion defect.
The myocardial supply/demand balance is af-
ected by numerous factors such as ventricular wall
tress, blood pressure-heart rate product, myocar-
ial contractility, ischemic conditioning, individual
ngina perception threshold, and autonomic dys-
unction with aging and diabetes, adding biological
ariability to our data. Therefore, Figure 3 reflects
his biological variability, not the error range of a
iagnostic test compared with some other “gold
tandard” for which ROC analysis is commonly
sed. Moreover, biological variation in flow thresh-
lds for ischemia would reduce observed differences
mong groups. Data analysis after removing dia-
etic patients (n  169, 10%), who might not
xperience angina, showed almost identical cutoffs
or definite ischemia (0.92 ml/min/g with AUC 
.98) and indeterminate clinical features ischemia
1.15 ml/min/g with AUC  0.86) as for the entire
roup. The lack of improvement in AUC after
djusting for PRP suggests that myocardial demand
as minimal differential impact, due both to the
elatively uniform PRP during dipyridamole in our
ohort and the minimal residual coupling between
ow and PRP during stress.
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998Submaximal vasodilation by dipyridamole, com-
pared with intravenous adenosine or intracoronary
papaverine, would reduce the separation between no and
definite ischemia groups. Our finding of an
AUC 0.98 for worst vasodilator stress flow suggests
that this was not a significant limitation. Definite
ischemia required a stress-induced uptake defect5%
in the amount of LV 60% of relative maximum
ctivity. Additionally, a 5  5 smoothing filter was
applied before finding worst flow in a pixel 2.7 to 3.8
mm thick. Therefore, our flow thresholds involve
substantial amounts of myocardium, not random pixel
variability distinct from surrounding flow.
CONCLUS IONS
We quantified absolute flow in 1,674 PET studies.
Definite ischemia was defined as a dipyridamole-
induced perfusion defect with either significant6. Bettinardi V, Danna M, Savi A, et al.
Performance evaluation of the new
1
1
1
packages/ROCR/
cessed August 2, 20quiring treatment. A vasodilator stress perfusion
threshold of 0.91 ml/min/g optimally separated
definite from no ischemia with an AUC of 0.98 and
a CFR cutoff of 1.74 with an AUC  0.91,
reflecting excellent discrimination at the exact mo-
ment of definite ischemia. As pilot data, average
vasodilator stress flow and CFR improved to sub-
stantially above ischemic thresholds after successful
PCI. The application of the physiological observa-
tions from our data will require further extended
study before understanding their clinical relevance.
Our observations suggest quantitative myocardial
perfusion may be appropriate for a clinical trial of
managing suspected or established CAD.
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